Clinical Research on Reversion of Precancerous Lesions of Gastric Carcinoma by Compound Gastritis Mixture
10.3969/j.issn.1005-5304.2016.04.006
- VernacularTitle:复方胃炎合剂逆转胃癌前病变的临床研究
- Author:
Minghan HUANG
;
Jian HUANG
;
Sihan LI
;
Ping LIN
;
Jianlong LIN
;
Xin WANG
;
Guodong ZHONG
;
Hengqing HUANG
- Publication Type:Journal Article
- Keywords:
compound gastritis mixture;
precancerous lesions of gastric cancer;
clinical efficacy
- From:
Chinese Journal of Information on Traditional Chinese Medicine
2016;23(4):20-23
- CountryChina
- Language:Chinese
-
Abstract:
Objective To discuss the clinical efficacy of compound gastritis mixture (CGM) in treating precancerous lesions of gastric carcinoma (PLGC).Methods Totally 85 PLGC patients were randomly divided into treatment group and control group. The treatment group took CGM and the control group took Vitacoenzyme tablets. One therapeutic course was three months, and the treatment lasted for two courses. The clinical symptoms, electronic gastroscopy presentation, and pathological tissues before and after treatment were observed, the clinical efficacy was evaluated.Results There was statistical significance in TCM syndrome between the two groups (P<0.05), and the effective rate in the treatment group was more obvious than that in the control group (P<0.01). The symptoms of the two groups were significantly improved (P<0.05,P<0.01), but the improvements of the main symptoms in the treatment group were superior to those in the control group (P<0.05,P<0.01). The total effective rate of electronic gastroscopy presentation was 80.0% (36/45) in the treatment group, which was better than that of the control group (P<0.05). Pathological curative effects of chronic atrophic gastritis, intestinal metaplasia, and dysplasia in the treatment group were also better than those in the control group (P<0.05).Conclusion CGM has definite clinical efficacy in treating PLGC.
